¿Qué es? ¿Cuál es su utilidad clínica? ¿Cómo implementarlo? | 18 MAY 15

Ayuno intermitente y salud metabólica

Se resume la evidencia científica acerca de los beneficios para la salud que brindan los programas de ayuno intermitente.
Autor/a: Patterson RE, Laughlin GA; LaCroix AZ et al Intermittent fasting and human metabolic health
INDICE:  1.  | 2. 

1. Brongers HA. Instruction and Interpretation: Studies in Hebrew Language, Palestinian Archaeology and Biblical Exegesis. Brussels, Belgium: Brill Academic Publications; 1997.
2. Mosley M, Spencer M. The FastDiet: Lose Weight, Stay Healthy, and Live Longer with the Simple Secret of Intermittent Fasting. La Jolla, CA: Atria Books; 2013.
3. Varady KA, Hellerstein MK. Alternate-day fasting and chronic disease prevention: A
review of human and animal trials. Am J Clin Nutr. 2007; 86:7-13.
4. Rothschild J, Hoddy KK, Jambazian P, Varady KA. Time-restricted feeding and risk of metabolic disease: A review of human and animal studies. Nutr Rev. 2014; 72:308-318.
5. Halberg N, Henriksen M, Soderhamn N, et al. Effect of intermittent fasting and refeeding on insulin action in healthy men. J Appl Physiol. 2005; 99:2128-2136.
6. Heilbronn LK, Smith SR, Martin CK, Anton SD, Ravussin E. Alternate-day fasting in nonobese subjects: Effects on body weight, body composition, and energy
metabolism. Am J Clin Nutr. 2005;81: 69-73.
7. Horne BD, Muhlestein JB, Lappe DL, et al. Randomized cross-over trial of short term water-only fasting: Metabolic and cardiovascular consequences. Nutr Metab Cardiovasc Dis. 2013; 23:1050-1057.
8. Varady KA, Roohk DJ, McEvoy-Hein BK, Gaylinn BD, Thorner MO, Hellerstein MK. Modified alternate-day fasting regimens reduce cell proliferation rates to a similar extent as daily calorie restriction in mice. FASEB J. 2008; 22:2090-2096.
9. Varady KA, Roohk DJ, Hellerstein MK. Dose effects of modified alternate-day fasting regimens on in vivo cell proliferation and plasma insulin-like growth factor-1 in mice. J Appl Physiol. 2007; 103: 547-551.
10. Varady KA, Roohk DJ, Loe YC, McEvoy-Hein BK, Hellerstein MK. Effects of modified alternate-day fasting regimens on adipocyte size, triglyceride metabolism, and plasma adiponectin levels in mice. J Lipid Res. 2007; 48:2212-2219.
11. Varady KA, Hudak CS, Hellerstein MK. Modified alternate-day fasting and cardioprotection: Relation to adipose tissue dynamics and dietary fat intake. Metabolism. 2009; 58:803-811.
12. Williams KV, Mullen ML, Kelley DE, Wing RR. The effect of short periods of caloric restriction on weight loss and glycemic control in type 2 diabetes. Diabetes Care. 1998; 21:2-8.
13. Johnson JB, Summer W, Cutler RG, et al. Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic Biol Med. 2007; 42:665-674.
14. Varady KA, Bhutani S, Church EC, KlempelMC.Short-term modified alternate day fasting: A novel dietary strategy for weight loss and cardioprotection in obese adults. Am J Clin Nutr. 2009; 90:1138-1143.
15. Harvie MN, Pegington M, Mattson MP, et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: A randomized trial in young overweight women. Int J Obes Suppl. 2011; 35: 714-727.
16. Bhutani S, Klempel MC, Kroeger CM, Trepanowski JF, Varady KA. Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans. Obesity. 2013; 2:1370-1379.
17. Eshghinia S, Mohammadzadeh F. The effects of modified alternate-day fasting diet on weight loss and CAD risk factors in overweight and obese women. J Diabetes Metab Disord. 2013; 12:4.
18. Harvie MN, Wright C, Pegington M, et al. The effect of intermittent energy and carbohydrate restriction v. daily energy restriction on weight loss and metabolic disease risk markers in overweight women. Br J Nutr. 2013; 110:1534-1547.
19. Varady KA, Bhutani S, Klempel MC, et al. Alternate day fasting for weight loss in normal weight and overweight subjects: A randomized controlled trial. Nutr J. 2013; 12:146.
20. Varady KA. Intermittent versus daily calorie restriction: Which diet regimen is more effective for weight loss? Obes Rev. 2011; 12:e593-601.
21. Barnosky AR, Hoddy KK, Unterman TG, Varady KA. Intermittent fasting vs daily calorie restriction for type 2 diabetes prevention: A review of human findings. Transl Res. 2014; 164:302-311.
22. Hatori M, Vollmers C, Zarrinpar A, et al.Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab. 2012; 15:848-860.
23. LeCheminant JD, Christenson E, Bailey BW, Tucker LA. Restricting nighttime eating reduces daily energy intake in healthy young men: A short-term cross-over study. Br J Nutr. 2013; 110: 2108-2113.
24. Carlson O, Martin B, Stote KS, et al. Impact of reduced meal frequency without caloric restriction on glucose regulation in healthy, normal-weight middle-aged men and women. Metab Clin Exp. 2007; 56: 1729-1734.
25. Stote KS, Baer DJ, Spears K, et al. A controlled trial of reduced meal frequency without caloric restriction in healthy, normal-weight, middle-aged adults. Am J Clin Nutr. 2007; 85:981-988.
26. Sadeghirad B, Motaghipisheh S, Kolahdooz F, Zahedi MJ, Haghdoost AA. Islamic fasting and weight loss: A systematic review and meta-analysis. Public Health Nutr. 2014; 17:3396-3406.
27. Kul S, Savas E, Ozturk ZA, Karadag G. Does Ramadan fasting alter body weight and blood lipids and fasting blood glucose in a healthy population? A meta-analysis. J Relig Health. 2013; 16:1217-1222.
28. Aksungar FB, Topkaya AE, Akyildiz M. Interleukin-6, C-reactive protein and biochemical parameters during prolonged intermittent fasting. Ann Nutr Metab. 2007; 51:88-95.
29. Faris MA, Kacimi S, Al-Kurd RA, et al. Intermittent fasting during Ramadan attenuates proinflammatory cytokines and immune cells in healthy subjects. Nutr Res. 2012; 32:947-955.
30. Horne BD, May HT, Anderson JL, et al. Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiography. Am J Cardiol. 2008; 102: 814-819.
31. Fraser GE, Shavlik DJ. Ten years of life: Is it a matter of choice? Arch Intern Med. 2001; 161(13):1645-1652.
32. Kelly CJ. A controlled trial of reduced meal frequency without caloric restriction in healthy, normal-weight, middle aged adults. Am J Clin Nutr. 2007;86: 1254-1255.
33. Longo VD, Mattson MP. Fasting: Molecular mechanisms and clinical applications. Cell Metab. 2014; 19:181-192.
34. Panda S, Hogenesch JB, Kay SA. Circadian rhythms from flies to human. Nature. 2002;417:329-335.
35. Froy O, Miskin R. Effect of feeding regimens on circadian rhythms: Implications for aging and longevity. Aging. 2010; 2:7-27.
Challet E. Circadian clocks, food intake, and metabolism. Prog Mol Biol Transl Sci. 2013; 119:105-135.
37. Scheer FA, Hilton MF, Mantzoros CS, Shea SA. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci USA. 2009; 106:4453-4458.
38. Eckel-Mahan KL, Patel VR, de Mateo S, et al. Reprogramming of the circadian clock by nutritional challenge. Cell. 2013; 155:1464-1478.
39. Sensi S, Pace Palitti V, Guagnano MT. Chronobiology in endocrinology. Ann Ist Super Sanita. 1993; 29:613-631.
40. Straif K, Baan R, Grosse Y, et al. Carcinogenicity of shift-work, painting, and firefighting. Lance Oncol. 2007; 8:1065-1066.
41. Stevens RG, Blask DE, Brainard GC, et al. Meeting report: The role of environmental lighting and circadian disruption in cancer and other diseases. Environ Health Perspect. 2007; 115:1357-1362.
42. Stevens RG, Rea MS. Light in the built environment: Potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Cause Control. 2001; 12:279-287.
43. Grundy A, Richardson H, Burstyn I, et al. Increased risk of breast cancer associated with long-term shift work in Canada. Occup Environ Med. 2013; 70:831-838.
44. Savvidis C, Koutsilieris M. Circadian rhythm disruption in cancer biology. Mol Med. 2012; 18:1249-1260.
45. Jakubowicz D, Barnea M, Wainstein J, Froy O. High caloric intake at breakfast vs. dinner differentially influences weight loss of overweight and obese women. Obesity. 2013; 21:2504-2512.
46. Cahill LE, Chiuve SE, Mekary RA, et al. Prospective study of breakfast eating and incident coronary heart disease in a cohort of male US health professionals. Circulation. 2013; 128:337-343.
47. Vander Wal JS. Night eating syndrome: A critical review of the literature. Clin Psychol Rev. 2012; 32:49-59.
48. Qin LQ, Li J, Wang Y, Wang J, Xu JY, Kaneko T. The effects of nocturnal life on endocrine circadian patterns in healthy adults. Life Sci. 2003; 73:2467-2475.
49. Bo S, Musso G, Beccuti G, et al. Consuming more of daily caloric intake at dinner predisposes to obesity. A 6-year population-based prospective cohort study. PLoS One. 2014; 24;9:e108467.
50. Sanders SW, Moore JG. Gastrointestinal chronopharmacology: Physiology, pharmacology and therapeutic implications. Pharmacol Ther. 1992; 54:1-15.
51. Ekmekcioglu C, Touitou Y. Chronobiological aspects of food intake and metabolism and their relevance on energy balance and weight regulation. Obes Rev. 2011; 12:14-25.
52. Ridaura VK, Faith JJ, Rey FE, et al. Cultured gut microbiota from twins discordant for obesity modulate adiposity and metabolic phenotypes in mice. Science.
2013; 341:10.
53. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006; 444:1027-1031.
54. Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest. 2011; 121:2126-2132.
55. Shen J, Obin MS, Zhao L. The gut microbiota, obesity and insulin resistance. Mol Aspect Med. 2013; 34:39-58.
56. Thaiss CA, Zeevi D, Levy M, et al. transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Cell. 2014; 159:514-529.
57. Freedman LS, Commins JM, Moler JE, et al. Pooled results from 5 validation studies of dietary self-report instruments using recovery biomarkers for energy and protein intake. Am J Epidemiol. 2014; 180: 172-188.
58. Schiavo-Cardozo D, Lima MM, Pareja JC, Geloneze B. Appetite-regulating hormones from the upper gut: Disrupted control of xenin and ghrelin in night workers. Clin Endocrinol. 2013;79:807-811.
59. Crispim CA, Waterhouse J, Damaso AR, et al. Hormonal appetite control is altered by shift work: A preliminary study. Metab Clin Exp. 2011; 60:1726-1735.
60. Wirth MD, Burch J, Shivappa N, et al. Dietary inflammatory index scores differ by shift work status: NHANES 2005 to 2010. J Occup Environ Med. 2014; 56: 145-148.
61. Antelmi E, Vinai P, Pizza F, Marcatelli M, Speciale M, Provini F. Nocturnal eating is part of the clinical spectrum of restless legs syndrome and an underestimated risk factor for increased body mass index. SleepMed. 2014; 15:168-172.
62. Yamaguchi M, Uemura H, Katsuura-Kamano S, et al. Relationship of dietary factors and habits with sleep-wake regularity. Asia Pac J Clin Nutr. 2013; 22:457- 465.
63. Gallicchio L, Kalesan B. Sleep duration and mortality: A systematic review and metaanalysis. J Sleep Res. 2009; 18:148-158.
64. Grandner MA, Hale L, Moore M, Patel NP. Mortality associated with short sleep duration: The evidence, the possible mechanisms, and the future. Sleep Med Rev. 2010; 14:191-203.
65. Spiegel K, Knutson K, Leproult R, Tasali E, Van Cauter E. Sleep loss: A novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol. 2005; 99:2008- 2019.
66. Buxton OM, Marcelli E. Short and long sleep are positively associated with obesity, diabetes, hypertension, and cardiovascular disease among adults in the United States. Soc Sci Med. 2010; 71:1027- 1036.
67. Patel SR, Hu FB. Short sleep duration and weight gain: a systematic review. Obesity. 2008; 16:643-653.
68. Ford ES, Li C, Wheaton AG, Chapman DP, Perry GS, Croft JB. Sleep duration and body mass index and waist circumference among U.S. adults. Obesity. 2014; 22:598-607.
69. Bass J, Takahashi JS. Circadian integration of metabolism and energetics. Science. 2010; 330:1349-1354.

 

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024